Shopping Cart
- Remove All
- Your shopping cart is currently empty
A2ti-1 is a highly selective inhibitor of annexin A2/S100A10 heterotetramer (A2t) (IC50: 24 μM) that inhibits ARV-mediated activation of Src and p38 mitogen-activated protein kinase (MAPK). A2ti-1 can be used to study human papillomavirus type 16 (HPV16) infection.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $90 | In Stock | |
5 mg | $222 | In Stock | |
10 mg | $347 | In Stock | |
25 mg | $689 | In Stock | |
50 mg | $1,090 | In Stock | |
100 mg | $1,490 | In Stock | |
500 mg | $2,980 | In Stock | |
1 mL x 10 mM (in DMSO) | $318 | In Stock |
Description | A2ti-1 is a highly selective inhibitor of annexin A2/S100A10 heterotetramer (A2t) (IC50: 24 μM) that inhibits ARV-mediated activation of Src and p38 mitogen-activated protein kinase (MAPK). A2ti-1 can be used to study human papillomavirus type 16 (HPV16) infection. |
Targets&IC50 | A2t:24 μM |
In vitro | The high-affinity A2ti-1 (100 μM; 72 h) reduces HPV16 PsV infection in HeLa cells in a dose-dependent manner[2]. |
Molecular Weight | 382.48 |
Formula | C20H22N4O2S |
Cas No. | 570390-00-0 |
Smiles | CCc1ccccc1-n1c(COc2ccccc2C)nnc1SCC(N)=O |
Relative Density. | 1.26 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (209.16 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.